Alpha CF (Schwabe North America, Inc)
Welcome to the PulseAid listing for the Alpha CF drug offered from Schwabe North America, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Schwabe North America, Inc |
| NON-PROPRIETARY NAME: | ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, IPECAC, PHOSPHORUSEUCALYPTUS GLOBULUS LEAF |
| SUBSTANCE NAME: | ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PHOSPHORUS; EUCALYPTUS GLOBULUS LEAF |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | SUBLINGUAL |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2004-07-01 |
| END MARKETING DATE: | 2018-03-31 |
Alpha CF HUMAN OTC DRUG Details:
| Item Description | Alpha CF from Schwabe North America, Inc |
| LABELER NAME: | Schwabe North America, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4; 4; 2; 4; 3; 6; 2([hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL) |
| START MARKETING DATE: | 2004-07-01 |
| END MARKETING DATE: | 2018-03-31 |
| PRODUCT ID: | 53499-0190_70e70b4d-b45e-4ac4-a59d-cff1ec2b75e8 |
| PRODUCT NDC: | 53499-0190 |
| APPLICATION NUMBER: | |
Other ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PHOSPHORUS; EUCALYPTUS GLOBULUS LEAF Pharmaceutical Manufacturers / Labelers:
